53 Recruiting Glioblastoma Phase 1 Clinical Trials
Active phase 1 studies for glioblastoma enrolling across the USA. Verify eligibility and contact site coordinators.
All Glioblastoma studiesPhase 1 Studies for Glioblastoma
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent.
📍 Col Uni Med Center New York Presby — New York, New York
View Study & Checklist ➔A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Trial of Niraparib in Participants With Newly-diagnosed Glioblastoma and Recurrent Glioma
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔Immunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults
📍 University of Alabama at Birmingham, Children's of Alabama — Birmingham, Alabama
View Study & Checklist ➔Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔Oral Gallium Maltolate for the Treatment of Relapsed and Refractory Glioblastoma
📍 Froedtert Hospital & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔Radiation/Temozolomide and Immunotherapy With Daratumumab to Improve Antitumor Efficacy in Glioblastoma
📍 West Virginia University Cancer Institute Mary Babb Randolph Cancer Center — Morgantown, West Virginia
View Study & Checklist ➔CART-EGFR-IL13Ra2 in Newly Diagnosed GBM Following Initial Radiotherapy
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔A Safety Study of Pharmacologic Ascorbate and Ferumoxytol in Addition to Standard of Care Chemoradiation in Glioblastoma
📍 Department of Radiation Oncology at University of Iowa — Iowa City, Iowa
View Study & Checklist ➔A Phase IB 2 Dose Trial of IRS-1 HSV C134 (IND 17296) Administered Intratumorally in Patients With Recurrent Malignant Glioma
📍 The University of Alabama at Birmingham Hospital — Birmingham, Alabama
View Study & Checklist ➔Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
📍 Massachusetts General Hospital — Boston, Massachusetts
View Study & Checklist ➔Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma
📍 Albert Einstein College of Medicine — The Bronx, New York
View Study & Checklist ➔Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Surgical Nivolumab And Ipilimumab For Recurrent GBM
📍 University of California Los Angeles — Los Angeles, California
View Study & Checklist ➔A Phase 1b / 2 Drug Resistant Immunotherapy With Activated, Gene Modified Allogeneic or Autologous γδ T Cells (DeltEx) in Combination With Maintenance Temozolomide in Subjects With Recurrent or Newly Diagnosed Glioblastoma
📍 University of Alabama at Birmingham — Birmingham, Alabama
View Study & Checklist ➔Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma
📍 M D Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔CART-EGFR-IL13Ra2 in EGFR Amplified Recurrent GBM
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔AZD1390 in Recurrent and Newly Diagnosed WHO Grade 4 Glioma Patients
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
View Study & Checklist ➔Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma
📍 Northwestern Memorial Hospital — Chicago, Illinois
View Study & Checklist ➔BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
📍 Children's Hospital Los Angeles — Los Angeles, California
View Study & Checklist ➔INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
📍 City of Hope — Duarte, California
View Study & Checklist ➔A Study Using Radiation Therapy and Temozolomide to Treat Glioblastoma in Patients Over 70
📍 James Graham Brown Cancer Center — Louisville, Kentucky
View Study & Checklist ➔Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma
📍 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center — Cleveland, Ohio
View Study & Checklist ➔AB154 Combined With AB122 for Recurrent Glioblastoma
📍 University of California San Francisco — San Francisco, California
View Study & Checklist ➔Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma
📍 Mayo Clinic Hospital - Phoenix — Phoenix, Arizona
View Study & Checklist ➔OKN-007 in Combination With Adjuvant Temozolomide Chemoradiotherapy for Newly Diagnosed Glioblastoma
📍 Stephenson Cancer Center, University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
View Study & Checklist ➔Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔Short Course Chemo-Radiation Therapy for Patients With Newly Diagnosed Glioblastoma
📍 University of Pittsburgh Medical Center, Radiation Oncology — Pittsburgh, Pennsylvania
View Study & Checklist ➔Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Phase 1/2 Study of Safety and Tolerability of MT-125 With Chemoradiation in Patients With Newly Diagnosed MGMT Methylated Glioblastoma
📍 Mayo Clinic Hospital — Phoenix, Arizona
View Study & Checklist ➔A Phase I First-in-human Trial of Bvax (B-cell Vaccination) in Addition to Standard of Care Chemoradiotherapy for Newly Diagnosed Glioblastoma
📍 Northwestern University — Chicago, Illinois
View Study & Checklist ➔Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency
📍 University of Cincinnati — Cincinnati, Ohio
View Study & Checklist ➔Combination ADI-PEG 20, TMZ, and RT for Treatment of Newly Diagnosed High-grade Glioma (HGG)
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔Phase I Trial of pH Resections of GBM at VA
📍 VA Greater Los Angeles Healthcare System, West Los Angeles, CA — West Los Angeles, California
View Study & Checklist ➔FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma
📍 City of Hope Medical Center — Duarte, California
View Study & Checklist ➔Oral Gallium Maltolate for Recurrent Glioblastoma
📍 Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin
View Study & Checklist ➔Multitracer [18F]Fluciclovine and 18F-FDG PET, and Advanced MRI for Metabolic Profiling of Glioblastoma
📍 Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔PH Sensitive MRI Based Resections of Glioblastoma
📍 Ronald Reagan Medical Center — Los Angeles, California
View Study & Checklist ➔Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
📍 Sibley Memorial Hospital — Washington D.C., District of Columbia
View Study & Checklist ➔Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ERAS-801 for the Treatment of Resectable and Progressive or Recurrent or Elderly Newly Diagnosed IDH Wildtype Grade IV Glioblastoma or Gliosarcoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
View Study & Checklist ➔Laser Interstitial Thermal Therapy (LITT) and Lomustine (CCNU) for Recurrent Glioblastoma
📍 University of California Davis Comprehensive Cancer Center — Sacramento, California
View Study & Checklist ➔A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
View Study & Checklist ➔Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
📍 Lenox Hill Brain Tumor Center — New York, New York
View Study & Checklist ➔Imaging Acetadote Metabolism in Glioblastoma
📍 University of Texas Southwestern Medical Center — Dallas, Texas
View Study & Checklist ➔CARv3-TEAM-E T Cells in Glioblastoma
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
View Study & Checklist ➔Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
📍 University of California, Los Angeles (Data Collection Only) — Los Angeles, California
View Study & Checklist ➔HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
📍 Houston Methodist Neurological Institute — Houston, Texas
View Study & Checklist ➔A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma
📍 Brigham and Women's Hospital — Boston, Massachusetts
View Study & Checklist ➔Pilot Trial for Treatment of Recurrent Glioblastoma
📍 Arthur J.E. Child Comprehensive Cancer Centre — Calgary, Alberta
View Study & Checklist ➔ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma
📍 Mayo Clinic in Rochester — Rochester, Minnesota
View Study & Checklist ➔Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
📍 Emory University Hospital/Winship Cancer Institute — Atlanta, Georgia
View Study & Checklist ➔